97
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Emergency Splenectomy in a Patient with Splenic Marginal Zone Lymphoma, Acute Portal Vein Thrombosis, and Chronic Viral Hepatitis B

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 431-434 | Published online: 09 Jun 2021

References

  • Zucca E, Arcaini L, Buske C, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(1):17–29. doi:10.1016/j.annonc.2019.10.010
  • Arcaini L, Rossi D, Paulli M. Splenic marginal zone lymphoma: from genetics to management. Blood. 2016;127(17):2072–2081. doi:10.1182/blood-2015-11-624312
  • Xiong W, Lv R, Li H, et al. Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma. Blood Cancer J. 2017;7(3):e548. doi:10.1038/bcj.2017.28
  • Ulcickas Yood M, Quesenberry CP, Guo D, et al. Incidence of non-Hodgkin’s lymphoma among individuals with chronic hepatitis B virus infection. Hepatology. 2007;46(1):107–112. doi:10.1002/hep.21642
  • Mahajan A, Wun T, Chew H, White RH. Lymphoma and venous thromboembolism: influence on mortality. Thromb Res. 2014;133(SUPPL. 2):S23–S28. doi:10.1016/S0049-3848(14)50004-7
  • Gangaraju R, Chen Y, Hageman L, et al. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation. Cancer. 2019;125(24):4498–4508. doi:10.1002/cncr.32488
  • Fedorova AS, Dmitriev VV, Lipay N, Markovets AF, Begun I, Dmitriev E. Venous thrombosis in children, adolescents and young adults with lymphomas: incidence, characteristics, risk factors and prognostic value. Oncogematologiya. 2018;13(2):9–20. doi:10.17650/1818-8346-2018-13-2-9-20
  • Martin SE, Abel RF. Splenic marginal zone lymphoma, iliac vein thrombosis, and monoclonal immunoglobulin Mκ antiphospholipid antibody with Annexin A5 interaction [16]. Leuk Lymphoma. 2006;47(9):1994–1996. doi:10.1080/10428190600731972
  • Yi S, Yan Y, Xiong W, et al. Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region. Oncotarget. 2017;8(58):98757–98770. doi:10.18632/oncotarget.21931
  • Dalia S, Suleiman Y, Croy DW, Sokol L. Association of lymphomagenesis and the reactivation of hepatitis B virus in non-hodgkin lymphoma. Cancer Control. 2015;22(3):360–365. doi:10.1177/107327481502200315
  • Sehn LH. Introduction to a review series: the paradox of indolent B-cell lymphoma. Blood. 2016;127(17):2045–2046. doi:10.1182/blood-2016-03-692442
  • Yıldız A, Albayrak M, Pala Ç, et al. The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: a 9-year single-center experience. J Oncol Pharm Pract. 2020;26(2):386–396. doi:10.1177/1078155219851540
  • Lenglet J, Traullé C, Mounier N, et al. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment. Leuk Lymphoma. 2014;55(8):1854–1860. doi:10.3109/10428194.2013.861067